Načítá se...
Physostigmine for dementia due to Alzheimer's disease
BACKGROUND: The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after it has been secreted into t...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2001
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8078195/ https://ncbi.nlm.nih.gov/pubmed/11405996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001499 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|